116 related articles for article (PubMed ID: 17666356)
21. [Expression of aFGF in ovarian epithelial cancer and its signal transduction pathway].
Zhang Y; Sun LG; Shang H; Gao H; Yu HY; Gao SM; Liu N
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):976-80. PubMed ID: 12899800
[TBL] [Abstract][Full Text] [Related]
22. RUNX3 protein is overexpressed in human epithelial ovarian cancer.
Nevadunsky NS; Barbieri JS; Kwong J; Merritt MA; Welch WR; Berkowitz RS; Mok SC
Gynecol Oncol; 2009 Feb; 112(2):325-30. PubMed ID: 18937968
[TBL] [Abstract][Full Text] [Related]
23. Expression and localization of aquaporin-5 in the epithelial ovarian tumors.
Yang JH; Shi YF; Cheng Q; Deng L
Gynecol Oncol; 2006 Feb; 100(2):294-9. PubMed ID: 16242760
[TBL] [Abstract][Full Text] [Related]
24. [Tissue microarray and in situ hybridization study on hypoxia inducible factor 1alpha mRNA expression in epithelial ovarian tumor].
Luo J; Peng ZL; Wang H; Cheng YF; Yang KX; Xie L; Qian XL; Zou Y
Zhonghua Zhong Liu Za Zhi; 2003 Mar; 25(2):168-70. PubMed ID: 12795846
[TBL] [Abstract][Full Text] [Related]
25. Expression of GLUT-1 glucose transporter in borderline and malignant epithelial tumors of the ovary.
Cantuaria G; Magalhaes A; Penalver M; Angioli R; Braunschweiger P; Gomez-Marin O; Kanhoush R; Gomez-Fernandez C; Nadji M
Gynecol Oncol; 2000 Oct; 79(1):33-7. PubMed ID: 11006027
[TBL] [Abstract][Full Text] [Related]
26. CD44 expression indicates favorable prognosis in epithelial ovarian cancer.
Sillanpää S; Anttila MA; Voutilainen K; Tammi RH; Tammi MI; Saarikoski SV; Kosma VM
Clin Cancer Res; 2003 Nov; 9(14):5318-24. PubMed ID: 14614016
[TBL] [Abstract][Full Text] [Related]
27. Increased staining for phosphorylated AKT and nuclear factor-kappaB p65 and their relationship with prognosis in epithelial ovarian cancer.
Guo RX; Qiao YH; Zhou Y; Li LX; Shi HR; Chen KS
Pathol Int; 2008 Dec; 58(12):749-56. PubMed ID: 19067848
[TBL] [Abstract][Full Text] [Related]
28. Oviductal glycoprotein, a new differentiation-based indicator present in early ovarian epithelial neoplasia and cortical inclusion cysts.
Woo MM; Gilks CB; Verhage HG; Longacre TA; Leung PC; Auersperg N
Gynecol Oncol; 2004 May; 93(2):315-9. PubMed ID: 15099939
[TBL] [Abstract][Full Text] [Related]
29. Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix.
Wu M; Gunning W; Ratnam M
Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):775-82. PubMed ID: 10498396
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal transformation in epithelial ovarian tumor cells expressing epidermal growth factor receptor variant III.
Zeineldin R; Rosenberg M; Ortega D; Buhr C; Chavez MG; Stack MS; Kusewitt DF; Hudson LG
Mol Carcinog; 2006 Nov; 45(11):851-60. PubMed ID: 16788982
[TBL] [Abstract][Full Text] [Related]
31. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.
Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K
Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936
[TBL] [Abstract][Full Text] [Related]
32. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
33. Differentiation margins of ovarian tumor pathology: first incidences of epithelial ovarian tumors monitored by marker antibodies.
van Niekerk CC; Vooijs P; Casparie-van Velsen IJ; Poels LG
Cancer Detect Prev; 1997; 21(3):247-57. PubMed ID: 9167042
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
35. Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer.
Davies EJ; Blackhall FH; Shanks JH; David G; McGown AT; Swindell R; Slade RJ; Martin-Hirsch P; Gallagher JT; Jayson GC
Clin Cancer Res; 2004 Aug; 10(15):5178-86. PubMed ID: 15297422
[TBL] [Abstract][Full Text] [Related]
36. Expression of nicotinic receptors in normal and tumoral pulmonary neuroendocrine cells (PNEC).
Sartelet H; Maouche K; Totobenazara JL; Petit J; Burlet H; Monteau M; Tournier JM; Birembaut P
Pathol Res Pract; 2008; 204(12):891-8. PubMed ID: 18667281
[TBL] [Abstract][Full Text] [Related]
37. Neuroendocrine differentiation in the progression of prostate cancer.
Komiya A; Suzuki H; Imamoto T; Kamiya N; Nihei N; Naya Y; Ichikawa T; Fuse H
Int J Urol; 2009 Jan; 16(1):37-44. PubMed ID: 19120524
[TBL] [Abstract][Full Text] [Related]
38. Neuroendocrine tumors of the ovary--a review.
Kupryjańczyk J
Verh Dtsch Ges Pathol; 1997; 81():253-9. PubMed ID: 9474878
[TBL] [Abstract][Full Text] [Related]
39. Numerical chromosomal aberrations in borderline, benign, and malignant epithelial tumors of the ovary: correlation with p53 protein overexpression and Ki-67.
Kohlberger PD; Kieback DG; Mian C; Wiener H; Kainz C; Gitsch G; Breitenecker G
J Soc Gynecol Investig; 1997; 4(5):262-4. PubMed ID: 9360232
[TBL] [Abstract][Full Text] [Related]
40. Expression of the jun family of genes in human ovarian cancer and normal ovarian surface epithelium.
Neyns B; Katesuwanasing ; Vermeij J; Bourgain C; Vandamme B; Amfo K; Lissens W; DeSutter P; Hooghe-Peters E; DeGrève J
Oncogene; 1996 Mar; 12(6):1247-57. PubMed ID: 8649827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
